512 research outputs found
The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer.
Summary
In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast cancer patient cohort of 82 breast
cancer patients. Immunohistochemical analysis was possible in 91.5% of the patients (75/82). Staining was evaluated using the
semi-quantitative assay according to Remmele and Stegner (immunoreactivity score [IRS]). IRS 0–1 was negative/very low, IRS
2–4 was moderate to high, and IRS 6–12 was high. Statistical analysis was performed by Spearman’s correlation test (p<0.05
significant). Overall survival was analyzed using Kaplan-Meier estimations. Only 6 patients had a negative IRS. Moderate IRS
values were present in 20 patients. Most of the patients had a high IRS (49). For survival analysis, data were dichotomized
(IRS 0–4: negative to moderate and IRS 6–12: high VDR expression). In univariate analysis, VDR expression showed significant
differences in progression-free survival (PFS) and overall survival (OS). Patients with high IRS scores showed significantly better
PFS and OS than patients with moderate/negative IRS scores for VDR expression. Tumor size was significantly correlated to
PFS. When analyzed separately, the three different IRS groups showed significant differences in VDR expression. The present
data suggest that VDR expression in breast cancer tissue may be of clinical significance, and the results provide evidence that
VDR may be a factor with prognostic relevance. (J Histochem Cytochem 60:121–129, 2012).
Keywords: breast cancer, vitamin D receptor, immunohistochemistry, prognosi
Hemolysis Pathways during Storage of Erythrocytes and Inter-Donor Variability in Erythrocyte Morphology
Adenomyoepithelial tumours and myoepithelial carcinomas of the breast – a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells
BACKGROUND: Adenomyoepithelial tumours and myoepithelial carcinomas of the breast are primarily defined by the presence of neoplastic cells with a myoepithelial immunophenotype. Current classification schemes are based on purely descriptive features and an assessment of individual prognosis is still problematic. METHODS: A series of 27 adenomyoepithelial tumours of the breast was analysed immunohistochemically with antibodies directed against various cytokeratins, p63, smooth muscle alpha-actin (SMA) and vimentin. Additionally, double immunofluorescence and comparative genomic hybridisation (CGH) was performed. RESULTS: Immunohistochemically, all the tumours showed a constant expression of high molecular weight cytokeratins (Ck) Ck5 and Ck14, p63, SMA and vimentin. With exception of one case diagnosed as myoepithelial carcinoma, all tested tumours expressed low molecular weight cytokeratin Ck18 in variable proportions of cells. Even in monophasic tumours lacking obvious glandular differentiation in conventional staining, a number of neoplastic cells still expressed those cytokeratins. Double immunofluorescence revealed tumour cells exclusively staining for Ck5/Ck14 in the presence of other cell populations that co-expressed high molecular weight Ck5/Ck14 as well as either low molecular weight Ck8/18 or SMA. Based on morphology, we assigned the series to three categories, benign, borderline and malignant. This classification was supported by a stepwise increase in cytogenetic alterations on CGH. CONCLUSION: Adenomyoepithelial tumours comprise a spectrum of neoplasms consisting of an admixture of glandular and myoepithelial differentiation patterns. As a key component SMA-positive cells co-expressing cytokeratins could be identified. Although categorisation of adenomyoepithelial tumours in benign, borderline and malignant was supported by results of CGH, any assessment of prognosis requires to be firmly based on morphological grounds. At present it is not yet clear, if and to what extent proposed Ck5-positive progenitor cells contribute to the immunohistochemical and morphological heterogeneity of these neoplasms of the breast
Relevance and Recent Developments of Chitosan in Peripheral Nerve Surgery
Developments in tissue engineering yield biomaterials with different supporting strategies to promote nerve regeneration. One promising material is the naturally occurring chitin derivate chitosan. Chitosan has become increasingly important in various tissue engineering approaches for peripheral nerve reconstruction, as it has demonstrated its potential to interact with regeneration associated cells and the neural microenvironment, leading to improved axonal regeneration and less neuroma formation. Moreover, the physiological properties of its polysaccharide structure provide safe biodegradation behavior in the absence of negative side effects or toxic metabolites. Beneficial interactions with Schwann cells (SC), inducing differentiation of mesenchymal stromal cells to SC-like cells or creating supportive conditions during axonal recovery are only a small part of the effects of chitosan. As a result, an extensive body of literature addresses a variety of experimental strategies for the different types of nerve lesions. The different concepts include chitosan nanofibers, hydrogels, hollow nerve tubes, nerve conduits with an inner chitosan layer as well as hybrid architectures containing collagen or polyglycolic acid nerve conduits. Furthermore, various cell seeding concepts have been introduced in the preclinical setting. First translational concepts with hollow tubes following nerve surgery already transferred the promising experimental approach into clinical practice. However, conclusive analyses of the available data and the proposed impact on the recovery process following nerve surgery are currently lacking. This review aims to give an overview on the physiologic properties of chitosan, to evaluate its effect on peripheral nerve regeneration and discuss the future translation into clinical practice
Rhodium-Complex-Functionalized and Polydopamine-Coated CdSe@CdS Nanorods for Photocatalytic NAD+ Reduction
[Image: see text] We report on a photocatalytic system consisting of CdSe@CdS nanorods coated with a polydopamine (PDA) shell functionalized with molecular rhodium catalysts. The PDA shell was implemented to enhance the photostability of the photosensitizer, to act as a charge-transfer mediator between the nanorods and the catalyst, and to offer multiple options for stable covalent functionalization. This allows for spatial proximity and efficient shuttling of charges between the sensitizer and the reaction center. The activity of the photocatalytic system was demonstrated by light-driven reduction of nicotinamide adenine dinucleotide (NAD(+)) to its reduced form NADH. This work shows that PDA-coated nanostructures present an attractive platform for covalent attachment of reduction and oxidation reaction centers for photocatalytic applications
Results from the DELCODE study
Previous studies have demonstrated increased tau plasma levels in patients
with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) due to AD.
Much less is known whether increased tau plasma levels can already be detected
in the pre-MCI stage of subjective cognitive decline (SCD). In the present
study we measured tau plasma levels in 111 SCD patients and 134 age- and
gender-matched cognitively healthy controls participating in the DZNE (German
Center for Neurodegenerative Diseases) longitudinal study on cognition and
dementia (DELCODE). Tau plasma levels were measured using ultra-sensitive,
single-molecule array (Simoa) technology. We found no significant different
tau plasma levels in SCD (3.4 pg/ml) compared with healthy controls (3.6
pg/ml) after controlling for age, gender, and education (p = 0.137). In
addition, tau plasma levels did not correlate with Aβ42 (r = 0.073; p =
0.634), tau (r = −0.179; p = 0.240), and p-tau181 (r = −0.208; p = 0.171)
cerebrospinal fluid (CSF) levels in a subgroup of 45 SCD patients with
available CSF. In conclusion, plasma tau is not increased in SCD patients. In
addition, the lack of correlation between tau in plasma and CSF in the
examined cohort suggests that tau levels are affected by different factors in
both biofluids
Results from the DELCODE study
Previous studies have demonstrated increased tau plasma levels in patients
with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) due to AD.
Much less is known whether increased tau plasma levels can already be detected
in the pre-MCI stage of subjective cognitive decline (SCD). In the present
study we measured tau plasma levels in 111 SCD patients and 134 age- and
gender-matched cognitively healthy controls participating in the DZNE (German
Center for Neurodegenerative Diseases) longitudinal study on cognition and
dementia (DELCODE). Tau plasma levels were measured using ultra-sensitive,
single-molecule array (Simoa) technology. We found no significant different
tau plasma levels in SCD (3.4 pg/ml) compared with healthy controls (3.6
pg/ml) after controlling for age, gender, and education (p = 0.137). In
addition, tau plasma levels did not correlate with Aβ42 (r = 0.073; p =
0.634), tau (r = −0.179; p = 0.240), and p-tau181 (r = −0.208; p = 0.171)
cerebrospinal fluid (CSF) levels in a subgroup of 45 SCD patients with
available CSF. In conclusion, plasma tau is not increased in SCD patients. In
addition, the lack of correlation between tau in plasma and CSF in the
examined cohort suggests that tau levels are affected by different factors in
both biofluids
The T-pod is as stable as supraacetabular fixation using 1 or 2 Schanz screws in partially unstable pelvic fractures: a biomechanical study
Introduction: Unstable fractures of the pelvis remain the predominant cause of severe hemorrhage, shock and early death in severely injured patients. The use of pelvic binders has become increasingly popular, particularly in the preclinical setting. There is currently insufficient evidence available about the stability of the pelvic binder versus supraacetabular fixation using 1 or 2 Schanz screws. We aimed to analyze the stability of the pelvic binder and supraacetabular fixateurs using either 1 or 2 Schanz screws in a cadaver model of an induced pelvic B-type fracture.
Materials and methods: The study was undertaken in 7 human fresh-frozen cadaveric pelvises with induced AO-type B fractures. Three stabilization techniques were compared: T-POD (pelvic bandage), supraacetabular external fixator with 1 pin on each side and external fixator with 2 pins on each side. Stability and stiffness were analyzed in a biomechanical testing machine using a 5-step protocol with static and dynamic loading, dislocation data were retrieved by ultrasound sensors at the fracture sites.
Results: No significant differences in fracture fragment displacement were detected when using either the T-POD, a 1-pin external fixator or a 2-pin external fixator (P > 0.05). The average difference in displacement between the three methods was < 1 mm.
Conclusions: Pelvic binders are suitable for reduction of pelvic B-type fractures. They provide stability comparable to that of supraacetabular fixators, independently of whether 1 or 2 Schanz screws per side are used. Pelvic binders provide sufficient biomechanical stability for transferring patients without the need to first replace them with surgically applied external fixators. However, soft tissue irritation has to be taken into consideration and prolonged wear should be avoided.
Level of evidence: Level III
- …